Mutation analysis of 20 SARS virus genome sequences: evidence for negative selection in replicase ORF1b and spike gene

Acta Pharmacol Sin. 2003 Aug;24(8):741-5.

Abstract

Aim: Recently, more SARS-CoV virus genome sequences are released to the GenBank database. The aim of this study is to reveal the evolution forces of SARS-CoV virus by analyzing the nucleotide mutations in these sequences.

Methods: We obtained 20 SARS-CoV virus genome sequences from NCBI database, and calculated the ratio of non-synonymous nucleotide substitution per non-synonymous site (Ka) and synonymous nucleotide substitution per synonymous site (Ks) for SARS-CoV virus genes.

Results: The Ka/Ks ratios for replicase polyprotein ORF1a, ORF1b, and spike protein gene are 1.09 (P=0.6501), 0.38 (P=0.0074), 0.65 (P=0.0685) respectively.

Conclusion: SARS-CoV virus replicase polyprotein ORF1b is undergoing negative selection; negative selection force is also probably operating on spike protein gene. These results provide basis for future developing a new drug and vaccine against SARS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Coronavirus M Proteins
  • DNA, Viral / analysis
  • DNA-Directed DNA Polymerase / genetics*
  • Genome, Viral*
  • Membrane Glycoproteins / genetics*
  • Molecular Sequence Data
  • Mutation*
  • Open Reading Frames / genetics
  • Sequence Alignment
  • Severe acute respiratory syndrome-related coronavirus / genetics*
  • Spike Glycoprotein, Coronavirus
  • Viral Envelope Proteins / genetics*
  • Viral Matrix Proteins / genetics

Substances

  • Coronavirus M Proteins
  • DNA, Viral
  • M protein, SARS-CoV
  • Membrane Glycoproteins
  • Spike Glycoprotein, Coronavirus
  • Viral Envelope Proteins
  • Viral Matrix Proteins
  • DNA replicase
  • DNA-Directed DNA Polymerase